US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.96

-0.2700-0.69%

Post-market: 39.230.2700+0.69%16:10 EDT

Volume:279

Turnover:10.81K

Market Cap:7.79M

PE:- -

High:38.96

Open:39.22

Low:38.96

Close:39.23

52wk High:43.01

52wk Low:24.96

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.12

T/O Rate:0.14%

Dividend:0.32

Dividend Rate:0.83%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D

Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding

Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment

Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing

THOMSON REUTERS

Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing

THOMSON REUTERS

Jiangxi Party Chief Inspects Ganjiang New Area, Urges Accelerated Industry Transformation and New Growth Drivers

Yin Hong Inspects Ganjiang New Area: Striving to Seize New Industrial Frontiers, Forge New Growth Drivers, and Demonstrate Excellence

PICC P&C Issues China's First Invasive Brain-Computer Interface Surgery Accident Insurance

Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta

J.P. Morgan Remains a Buy on Xenon (XENE)

Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)

Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)

Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live

Dianthus Therapeutics CEO Marino Garcia Reports Disposal of 166,000 Common Shares Worth $17.97 Million

Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date

MT Newswires Live

Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag

Scholar Rock to remove Catalent Indiana facility from apitegromab BLA

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/IBRN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":38.9601,"timestamp":1788206400000,"preClose":39.2301,"halted":0,"volume":279,"hourTrading":{"tag":"盘后","latestPrice":39.2301,"preClose":38.9601,"latestTime":"16:10 EDT","volume":7,"amount":272.7207,"timestamp":1788207004390,"change":0.27,"changeRate":0.00693,"amplitude":0},"delay":0,"changeRate":-0.006882470348023664,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Closed","change":-0.27,"latestTime":"08-31 16:00:00 EDT","open":39.22,"high":38.9601,"low":38.9601,"amount":10811,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":39.2301,"sharesOutstanding":150000,"nav":39.171708,"aum":7834341.6,"dividendRate":0.008257,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.2301,"preClose":38.9601,"latestTime":"16:10 EDT","volume":7,"amount":272.7207,"timestamp":1788207004390,"change":0.27,"changeRate":0.00693,"amplitude":0},"volumeRatio":0.121537,"impliedVol":0.124,"impliedVolPercentile":0.6653},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.121537,"shares":200000,"dividePrice":0.3217,"high":38.9601,"amplitude":0,"preClose":39.2301,"low":38.9601,"week52Low":24.9594,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":38.9601,"eps":0,"divideRate":0.008257,"volume":279,"delay":0,"ttmEps":0,"open":39.22,"prevYearClose":32.3193,"prevWeekClose":39.2301,"prevMonthClose":36.6044,"prevQuarterClose":38.8263,"fiveDayClose":39.5297,"twentyDayClose":36.6969,"sixtyDayClose":34.9273},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1155684243","title":"BofA Securities Boosts Targets on Chinese CXO Players as Strong Biotech Funding Fuels R&D","url":"https://stock-news.laohu8.com/highlight/detail?id=1155684243","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155684243?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:50","pubTimestamp":1786596641,"startTime":"0","endTime":"0","summary":"BofA Securities has released a report indicating that the Chinese CXO sector is poised to benefit from robust biotech venture capital funding. The bank notes that strong financing in the first half...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02359","LU1969619763.USD","APXH","IE00B543WZ88.USD","LU1303224171.USD","CXO","LU0320764599.SGD","LU1719994722.HKD","BK1141","603259","LU0611395673.USD","LU1251922891.USD","BK0216","BMED","WX","LU1934453819.USD","PSIL","LU0456842615.SGD","LU0708995583.HKD","LU2495084118.USD","LFSC","BK1576","LU1997245177.USD","MEDI","IBRN","IE00BPRC5H50.USD","LU1997245094.SGD","IDNA","IE00B5MMRT66.SGD","LU2488822045.USD","BK1583","XBIX","161027","LU0052750758.USD","LU0348767384.USD","LU2328871848.SGD","PSCH","SMCO","LU0700851271.USD","LU1808992512.USD","SURI","LU1046422090.SGD","BBC","LU2045819591.USD","FHLC","LU0348766576.USD","LU2125910500.SGD","LU1979443071.USD","LU1997244956.HKD","LU2242644610.SGD","LU1770034418.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111112440","title":"Bank of America Securities Raises Targets for Chinese CXO Firms on Strong Biotech Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=1111112440","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111112440?lang=en_us&edition=fundamental","pubTime":"2026-08-13 10:35","pubTimestamp":1786588544,"startTime":"0","endTime":"0","summary":"A report from Bank of America Securities indicates that Chinese CRO/CDMO companies are poised to benefit from robust first-half funding in the global and Chinese biotech sectors, along with active...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934453819.USD","LU1251922891.USD","LU1997245177.USD","LU0348735423.USD","BMED","BK1521","LU0417516902.SGD","SMCO","LFSC","LU0417516738.SGD","LU2328871848.SGD","LU0320764599.SGD","IE00B5MMRT66.SGD","SG9999002463.SGD","LU0128526141.USD","LU0348766576.USD","SURI","BK1583","LU0823426308.USD","LU1997244956.HKD","LU1979443071.USD","LU0700851271.USD","LU2125910500.SGD","LU1997245094.SGD","LU0819121731.USD","IBRN","CXO","LU0039217434.USD","161027","LU0572944931.SGD","BK1576","LU0140636845.USD","LU3063872942.SGD","LU0181495838.USD","WX","LU1242518931.SGD","LU0856984785.SGD","LU0516423091.SGD","LU0327786744.USD","LU0456827905.SGD","02269","603259","PSCH","LU0359202008.SGD","LU0052750758.USD","LU0359201612.USD","LU0611395673.USD","LU0456846285.SGD","LU0456842615.SGD","LU0516422440.USD","LU1720050803.USD","LU1770034418.SGD","03759","LU0348767384.USD","LU2242644610.SGD","APXH","BK1141","LU1046422090.SGD","LU1969619763.USD","MEDI","LU1808992512.USD","LU2039709279.SGD","LU0043850808.USD","02359","LU1242518857.USD","LU0348825331.USD","LU0326950275.SGD","KURE","BBC","FHLC","IE00B543WZ88.USD","LU0051755006.USD","IE00B0JY6N72.USD","LU0307460666.USD","LU1688375341.USD","LU1719994722.HKD","LU0516422366.SGD","LU0029874061.USD","LU0823426480.USD","LU2488822045.USD","LU2045819591.USD","BK0216","BK1589","LU1794554557.SGD","LU0979878070.USD","LU1303224171.USD","LU1880383366.USD","PSIL","LU0516422952.EUR","LU0588546209.SGD","BK1610","LU0708995583.HKD","XBIX","IE00BPRC5H50.USD","IDNA","LU2495084118.USD","SG9999002562.SGD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658906555","title":"Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment","url":"https://stock-news.laohu8.com/highlight/detail?id=2658906555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658906555?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:19","pubTimestamp":1786547988,"startTime":"0","endTime":"0","summary":"Alkermes cuts interest spreads on $1.52 billion term loan facilities via credit agreement amendmentAlkermes entered an amendment on Aug. 12, 2026 to its Feb. 12, 2026 credit agreement with JPMorgan Chase Bank.The deal covers senior secured term loan A of USD 745.31 million, due Feb. 12, 2031, and term loan B of USD 773.06 million, due Aug. 12, 2031.The amendment cuts the interest spread by 0.75% on the term loan A facility, 0.5% on the term loan B facility.Term loan A now prices at Term SOFR plus 1.75%-2.25%, or base rate plus 0.75%-1.25%, based on secured net leverage.Term loan B now prices at Term SOFR plus 2.25%, or base rate plus 1.25%.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL3L5Jbs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KBWB","LU1162221912.USD","PSCH","LU1974910355.USD","TFNS","JPO","IYF","LU2456880835.USD","LU2552382215.SGD","LU1551013425.SGD","IE00BZ1G4Q59.USD","LU0211331839.USD","LU2505996681.GBP","JPMO","LU0234572021.USD","LU0208291251.USD","IBRN","LU2023250843.SGD","LU0265550946.USD","LU2054465674.USD","VFH","LU0320765646.SGD","LU0106261372.USD","LU1363072403.SGD","IE00BYXW3230.USD","LU2237443622.USD","PSIL","FNCL","LU1720051017.SGD","LU0320765489.SGD","ALKS","IXG","TRUF","IYG","LU1629891620.HKD","LU1116320901.HKD","LU2106854487.HKD","FBT","LU2462157665.USD","JPX","LU2552382132.HKD","LU0211326755.USD","LU0496365809.HKD","LU2357305700.SGD","LU1496350502.SGD","MEDX","FTXO","XLF","UYG","LU0345770993.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908840","title":"Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908840","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908840?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PSIL","FBT","ALKS","IBRN","BK4139","MEDX","PSCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908808","title":"Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908808","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908808?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541257,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491BU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","IBRN","FBT","PSIL","BK4139","PSCH","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107826889","title":"Jiangxi Party Chief Inspects Ganjiang New Area, Urges Accelerated Industry Transformation and New Growth Drivers","url":"https://stock-news.laohu8.com/highlight/detail?id=1107826889","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107826889?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:40","pubTimestamp":1786538436,"startTime":"0","endTime":"0","summary":"A provincial official, Yin Hong, visited the Ganjiang New Area on August 12, emphasizing the need to fully implement the spirit of the 15th Provincial Committee's 10th Plenary Session. He urged the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178440125","title":"Yin Hong Inspects Ganjiang New Area: Striving to Seize New Industrial Frontiers, Forge New Growth Drivers, and Demonstrate Excellence","url":"https://stock-news.laohu8.com/highlight/detail?id=1178440125","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178440125?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:01","pubTimestamp":1786536063,"startTime":"0","endTime":"0","summary":"On August 12, Yin Hong, Secretary of the Provincial Party Committee, conducted an in-depth inspection of the Ganjiang New Area. He emphasized the need to fully implement the spirit of the 15th...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136280436","title":"PICC P&C Issues China's First Invasive Brain-Computer Interface Surgery Accident Insurance","url":"https://stock-news.laohu8.com/highlight/detail?id=1136280436","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136280436?lang=en_us&edition=fundamental","pubTime":"2026-08-12 11:08","pubTimestamp":1786504105,"startTime":"0","endTime":"0","summary":"On August 12, PICC Property and Casualty Company Limited, a subsidiary of People's Insurance Company (Group) of China Limited (01339), announced it has underwritten the country's first invasive...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658468579","title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","url":"https://stock-news.laohu8.com/highlight/detail?id=2658468579","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658468579?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:09","pubTimestamp":1786482556,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics SVP General Counsel Adam Veness melepas saham senilai USD 2,21 jutaSVP, General Counsel dan Secretary Adam M Veness melepas seluruh kepemilikan saham biasa Dianthus Therapeutics.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4W8dyv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics SVP General Counsel Adam Veness Melepas Saham Senilai USD 2,21 Juta","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DNTH","IBRN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658343990","title":"J.P. Morgan Remains a Buy on Xenon (XENE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658343990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658343990?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:56","pubTimestamp":1786449382,"startTime":"0","endTime":"0","summary":"In a report released today, Tessa Romero from J.P. Morgan maintained a Buy rating on Xenon, with a price target of $82.00. Romero covers the Health...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-remains-a-buy-on-xenon-xene-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1064131342.USD","LU2133065610.SGD","LU0225283273.USD","LU1732799900.SGD","LU0795875169.SGD","BK4534","LU1791710582.SGD","XENE","BK4588","LU1363072403.SGD","LU0971096721.USD","LU0314104364.USD","LU0106831901.USD","LU1244550577.SGD","LU1989772923.USD","LU2271345857.HKD","LU2089283258.USD","BK4139","LU0795875086.SGD","IBRN","LU0053666078.USD","LU0158827781.USD","LU1548497426.USD","IE00B3S45H60.SGD","SBIO","KBWB","LU1074936037.SGD","IE00B775SV38.USD","LU1244550221.USD","LU2023251221.USD","LU1791710400.SGD","LU0320765646.SGD","LU1668664300.SGD","LU1732800096.USD","IAI","LU2357305700.SGD","LU0106261372.USD","LU0882574139.USD","LU1720051017.SGD","LU0210528500.USD","LU1244550494.USD","LU2089284900.SGD","LU0390134368.USD","LU2028103732.USD","BK4516","LU0912757837.SGD","LU2264538146.SGD","LU1720051108.HKD","LU0234570918.USD","LU0098860793.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658966867","title":"Analysts’ Top Healthcare Picks: Dianthus Therapeutics (DNTH), Elanco Animal Health (ELAN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658966867","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658966867?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:20","pubTimestamp":1786414812,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dianthus Therapeutics (DNTH), Elanco Animal Health (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-dianthus-therapeutics-dnth-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DNTH","LU1941712264.USD","LU0029874061.USD","XLV","BK4581","IBRN","LU1941712348.USD","LU0128526141.USD","ELAN","BK4561","BK4585","LABU","HCSG","BK4137","BK4588","BK4007","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939006","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS) and Dianthus Therapeutics (DNTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658939006?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:50","pubTimestamp":1786366208,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Hims & Hers Health (HIMS) and Dianthus Therapeutic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-and-dianthus-therapeutics-dnth-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLAM","HMYY","HIYY","IBRN","DNTH","HIMZ","BK4139","HIMS","THNR","HEAL","HIMY","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658987680","title":"Scholar Rock Holding Price Target Maintained with a $65.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658987680","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658987680?lang=en_us&edition=fundamental","pubTime":"2026-08-10 18:14","pubTimestamp":1786356840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SRRK/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","THNR","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658982377","title":"Analysts Offer Insights on Healthcare Companies: Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx Pharmaceuticals Inc (AMLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658982377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658982377?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:40","pubTimestamp":1786354831,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Xenon (XENE), Relay Therapeutics (RLAY) and Amylyx P...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-relay-therapeutics-rlay-and-amylyx-pharmaceuticals-inc-amlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-xenon-xene-relay-therapeutics-rlay-and-amylyx-pharmaceuticals-inc-amlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XBI","IBRN","HCSG","RLAY","BK4585","XLV","BK4581","XENE","BK4139","BK4137","BK4563","LU0128526141.USD","SBIO","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658347984","title":"Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2658347984","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658347984?lang=en_us&edition=fundamental","pubTime":"2026-08-10 17:19","pubTimestamp":1786353580,"startTime":"0","endTime":"0","summary":"(Updates with day of announcement in first paragraph, Novo Nordisk's affiliation in the second paragraph, and latest stock moves in the fourth paragraph.)Scholar Rock Holding (SRRK) said Friday that t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IBRN","THNR","BK4139","SRRK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657193621","title":"Dianthus Therapeutics CEO Marino Garcia Reports Disposal of 166,000 Common Shares Worth $17.97 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657193621","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657193621?lang=en_us&edition=fundamental","pubTime":"2026-08-08 06:31","pubTimestamp":1786141877,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics CEO Marino Garcia reports disposal of 166,000 common shares worth $17.97 millionDianthus Therapeutics CEO and President Marino Garcia reported option exercises and share sales on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDLbvQy8D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Dianthus Therapeutics CEO Marino Garcia Reports Disposal of 166,000 Common Shares Worth $17.97 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","DNTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629325","title":"Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629325","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629325?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:46","pubTimestamp":1786135593,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding (SRRK) said the FDA review of its apitegromab Biologics License Application for spinal muscular atrophy remains on track for potential approval by the September 30 PDUFA date, wit","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SRRK","BK4139","IBRN","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657629331","title":"Scholar Rock Holdings Pulls Novo Nordisk Facility from Drug Application After FDA Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=2657629331","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657629331?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:46","pubTimestamp":1786135560,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding is removing one Novo Nordisk-owned fill-finish facility from its biologics license application for apitegromab to treat spinal muscular atrophy, after the facility was flagged for possible enforcement by the Food and Drug Administration.The biopharmaceutical company said the application will proceed with a second fill-finish facility -- a U.S.-based facility in good standing with the FDA and European regulators -- and is on track for potential FDA approval by Sept. 30.Scholar Rock said it received a customer notification on Friday that the FDA classified the first fill-finish facility, Novo Nordisk-owned Catalent Indiana, as Official Action Indicated following an April site inspection. The classification means that regulatory and/or administrative actions are recommended, according to the FDA.\"Scholar Rock will continue to collaborate closely with the FDA and under their guidance, will remove Catalent Indiana from the apitegromab BLA,\" the company said. \"FDA review","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","BK4532","BK4585","IE00BKVL7J92.USD","THNR","SRRK","NVO","LU1093756325.SGD","BK4599","IBRN","BK4007","LU0154236417.USD","LU1093756168.USD","OZEM","NVOH","BK4588","IE00BZ1G4Q59.USD","BK4139","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657072626","title":"Scholar Rock to remove Catalent Indiana facility from apitegromab BLA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657072626","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657072626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:30","pubTimestamp":1786134642,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA review of the apitegromab biologics license application, or BLA, for the treatment of children and adult...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-to-remove-catalent-indiana-facility-from-apitegromab-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-to-remove-catalent-indiana-facility-from-apitegromab-bla-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","THNR","BK4585","BK4139","IBRN","SRRK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657260426","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657260426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657260426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:30","pubTimestamp":1786134613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD), GH Research (GHRS) and Scholar Rock...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","GH","GDOC","INMD","XLV","BK4581","XBI","SRRK","HELX","LABU","BK4082","EKG","GNOM","BK4137","THNR","PTH","LU0889565916.HKD","LU0029874061.USD","LFSC","BK4139","BK4007","BK4551","BK4535","LU0109394709.USD","HCSG","GNMX","PSIL","IBRN","LU0128526141.USD","BK4196","GHRS","LU0320765992.SGD","BK4539","BK4585","FFOX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}